These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15340530)

  • 1. [Antisense oligonucleotide inhibition of coxsackievirus B3 gene expression in HeLa cells and dose-response experiments].
    Liu ZW; Sun HM; Xiao ZH; Qiu N; Zhang T; Zhao JM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):62-5. PubMed ID: 15340530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antisense oligonucleotides resistance to coxsackievirus B3 infection in HeLa cells].
    Sun H; Liu Z; Zhang T
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):295-7. PubMed ID: 11860805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human cytomegalovirus replication in a human retinal epithelial cell model by antisense oligonucleotides.
    Detrick B; Nagineni CN; Grillone LR; Anderson KP; Henry SP; Hooks JJ
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):163-9. PubMed ID: 11133862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro mutational and inhibitory analysis of the cis-acting translational elements within the 5' untranslated region of coxsackievirus B3: potential targets for antiviral action of antisense oligomers.
    Yang D; Wilson JE; Anderson DR; Bohunek L; Cordeiro C; Kandolf R; McManus BM
    Virology; 1997 Feb; 228(1):63-73. PubMed ID: 9024810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the inhibitory effect of antisense phosphorothioate oligodeoxynucleotide on coxsackie virus B replication in vitro.
    Qi X; Li X; Liu M
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Sep; 14(3):253-6. PubMed ID: 11498691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
    Soler M; McHutchison JG; Kwoh TJ; Dorr FA; Pawlotsky JM
    Antivir Ther; 2004 Dec; 9(6):953-68. PubMed ID: 15651754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells.
    Hatta T; Takai K; Nakada S; Yokota T; Takaku H
    Biochem Biophys Res Commun; 1997 Mar; 232(2):545-9. PubMed ID: 9125219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific inhibition of coxsackievirus B3 translation and replication by phosphorothioate antisense oligodeoxynucleotides.
    Wang A; Cheung PK; Zhang H; Carthy CM; Bohunek L; Wilson JE; McManus BM; Yang D
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1043-52. PubMed ID: 11257014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hepatitis C virus replication by antisense oligonucleotide in culture cells.
    Mizutani T; Kato N; Hirota M; Sugiyama K; Murakami A; Shimotohno K
    Biochem Biophys Res Commun; 1995 Jul; 212(3):906-11. PubMed ID: 7626129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of hepatitis B virus in vitro by antisense oligonucleotides.
    Yao ZQ; Zhou YX; Guo J; Feng ZH; Feng XM; Chen CX; Jiao JZ; Wang SQ
    Acta Virol; 1996 Feb; 40(1):35-9. PubMed ID: 8886096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes.
    Hanecak R; Brown-Driver V; Fox MC; Azad RF; Furusako S; Nozaki C; Ford C; Sasmor H; Anderson KP
    J Virol; 1996 Aug; 70(8):5203-12. PubMed ID: 8764029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
    Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition of hepatitis B viral gene expression by antisense phosphrothioate oligonucleotides].
    Yao ZQ; Zhou YX; Wang AL
    Zhonghua Yi Xue Za Zhi; 1994 Feb; 74(2):74-6, 125. PubMed ID: 8069724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of secondary structure of the spacer region within the 5'-untranslated region of the coxsackievirus B3 RNA: possible role of an apical GAGA loop in binding La protein and influencing internal initiation of translation.
    Bhattacharyya S; Das S
    Virus Res; 2005 Mar; 108(1-2):89-100. PubMed ID: 15681059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative levels of inhibition of p24 gene expression by different 20-mer antisense oligonucleotide sequences targeting nucleotides + 1129 to + 1268 of the HIV-1 gag genome: an analysis of mechanism.
    Anazodo MI; Duta E; Friesen AD; Wright JA
    Biochem Biophys Res Commun; 1996 Dec; 229(1):305-9. PubMed ID: 8954123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand.
    Yuan J; Cheung PK; Zhang HM; Chau D; Yang D
    J Virol; 2005 Feb; 79(4):2151-9. PubMed ID: 15681418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo inhibition of hepatitis B virus gene expression by antisense phosphorothioate oligonucleotides.
    Moriya K; Matsukura M; Kurokawa K; Koike K
    Biochem Biophys Res Commun; 1996 Jan; 218(1):217-23. PubMed ID: 8573134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activity and ocular kinetics of antisense oligonucleotides designed to inhibit CMV replication.
    Henry SP; Miner RC; Drew WL; Fitchett J; York-Defalco C; Rapp LM; Levin AA
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2646-51. PubMed ID: 11581212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel [(biphenyloxy)propyl]isoxazole derivatives for inhibition of human rhinovirus 2 and coxsackievirus B3 replication.
    Makarov VA; Riabova OB; Granik VG; Wutzler P; Schmidtke M
    J Antimicrob Chemother; 2005 Apr; 55(4):483-8. PubMed ID: 15743897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced antisense inhibition of human immunodeficiency virus type 1 in cell cultures by DLS delivery system.
    Lavigne C; Thierry AR
    Biochem Biophys Res Commun; 1997 Aug; 237(3):566-71. PubMed ID: 9299405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.